The patient had an unreported heterozygous de novo sequence variant in ATP1A3, and have been found to be of a phenotype characterized by early-onset attacks of movement disorders, which proved to be epileptic, and severe developmental delay. Here, ATP1A3 is linked to Global developmental delay.